| |
n
|
Group 1
|
Group 2
|
Group 3
|
Group 4
|
|---|
| | |
50
|
17
|
57
|
39
|
|---|
|
CA125
|
Mean
|
16.8
|
19.9
|
46.1
|
1976.3
|
|
U/mL
|
SD
|
8.6
|
20.5
|
34
|
7390.4
|
| |
Median(range)
|
14 (9–47)
|
13 (9–97)
|
38 (8–167)a
|
480 (8–46210)a,b
|
|
HE4
|
Mean
|
48.6
|
60.6
|
53.8
|
508.3
|
|
pmol/L
|
SD
|
13.6
|
26.5
|
15.3
|
301.5
|
| |
Median(range)
|
47 (24–103)
|
58 (30–125)
|
53 (26–98)
|
426 (48–850)a,b
|
|
CA72-4
|
Mean
|
2.8
|
2.7
|
3
|
39.8
|
|
U/mL
|
SD
|
0.45
|
0.32
|
0.98
|
45.1
|
| |
Median(range)
|
2.7 (2.1 - 4)
|
2.8 (2.1 - 3.3)
|
2.7 (1.8 -6.2)
|
7 (1–112)a,b
|
-
ap-value < 0.05 vs Group 1 (healthy); bp-value < 0.05 vs Group 2 (Benign) and Group 3 (endometriosis); Group 4 (ovarian cancer).
